RU 486 (MifePristone) : Conditional Approval by the Food and Drug Administration.

Details discovery, research, and marketing of mifepristone, also known as RU 486, a drug that prevents or interrupts a pregnancy. Reviews efficacy and safety considerations of RU 486 and examines provisional FDA approval and related issues.

Bibliographic Details
Corporate Authors:	Library of Congress. Congressional Research Service, ProQuest (Firm)
Format:	eBook
Language:	English
Published:	[Place of publication not identified] : [publisher not identified], 1997.
Series:	U.S. Congressional Research.
Subjects:	Abortion. Drugs. Family planning. Electronic books.
Online Access:	Connect to the full text of this electronic book

Description
Summary:	Details discovery, research, and marketing of mifepristone, also known as RU 486, a drug that prevents or interrupts a pregnancy. Reviews efficacy and safety considerations of RU 486 and examines provisional FDA approval and related issues.
Item Description:	Record is based on bibliographic data in ProQuest U.S. Congressional Research Digital Collection (last viewed July 2010). Reuse except for individual research requires license from ProQuest, LLC. CRS Report. Electronic resource.
Physical Description:	1 online resource.